Related Experiment Video
Updated: Feb 23, 2026

08:27
Muscle Velocity Recovery Cycles to Examine Muscle Membrane Properties
Published on: February 19, 2020
14.8K
[Critical illness myopathy and polyneuropathy].
1Universitätsklinik für Neurologie der Paracelsus Medizinischen Privatuniversität, Klinikum Nürnberg, Breslauer Str. 201, 90471, Nürnberg, Deutschland.
Medizinische Klinik, Intensivmedizin Und Notfallmedizin
|September 7, 2017
Summary
Intensive care unit-acquired weakness (ICUAW) affects 50-80% of patients, stemming from nerve and muscle damage. Neuropathy, a component of ICUAW, often causes long-term paralysis and balance issues.
Area of Science:
- Neurology
- Intensive Care Medicine
- Rehabilitation
Background:
- Neuromuscular dysfunction, including critical illness polyneuropathy and myopathy, affects a significant majority of intensive care unit (ICU) patients.
- The term intensive care unit-acquired weakness (ICUAW) is now preferred to describe these conditions, encompassing both nerve and muscle damage.
- While pure myopathy is common, pure neuropathy is rare, with mixed forms occurring in 30-50% of cases.
Purpose of the Study:
- To review the incidence, risk factors, and long-term consequences of intensive care unit-acquired weakness (ICUAW).
- To highlight the distinction between myopathy and neuropathy components of ICUAW and their differential impact on patient recovery.
- To emphasize the prevalence and persistence of functional impairments following ICU stays.
Main Methods:
- Literature review of studies on neuromuscular complications in critically ill patients.
- Analysis of risk factors associated with the development of ICUAW, such as sepsis, multiorgan dysfunction, and ARDS.
- Examination of the long-term sequelae of ICUAW, including paralysis, sensory disturbances, and balance problems.
Main Results:
- 50-80% of ICU patients experience neuromuscular disturbances, broadly termed ICUAW.
- Sepsis, multiorgan dysfunction, and acute respiratory distress syndrome (ARDS) are key risk factors for ICUAW development.
- Approximately one-third of patients have persistent impairments upon ICU discharge, with 10% experiencing long-term issues, primarily linked to the neuropathic component.
Conclusions:
- Intensive care unit-acquired weakness (ICUAW) is a prevalent complication with significant long-term functional consequences for patients.
- The neuropathic component of ICUAW is particularly associated with persistent paralysis and balance disturbances.
- Early identification and management of risk factors are crucial to mitigate the long-term impact of ICUAW on patient recovery and quality of life.
More Related Videos
Related Concept Videos
Myasthenia Gravis: Overview and Treatment
3.1K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
3.1K
Myasthenia Gravis: Diagnostic Tests
2.8K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
2.8K
Disorders of the Skeletal Muscle
2.1K
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
2.1K
Myocarditis I: Introduction
476
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
476
Chemical Synapses
12.1K
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
12.1K
Chemical Synapses
4.8K
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
4.8K

